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Abstract 
Aims: The aim of this study is to investigate the toxicological and pharmacological 
aspects of the popular ayurvedic preparation Raktapittantaka Louha (RPT) which has been 
used for hyperacidity, non ulcer dyspepsia and hemorrhagic diseases. Methods: 
Raktapittantaka Louha was administered orally to male albino rat. After 46 days of treatment 
period animals were fasted for 18 hours after the last administration. Biochemical studies 
including; lipid profile, total protein, serum albumin, blood urea nitrogen, bilirubin, 
creatinine, aspartate aminotransferase, alanine aminotransferase & alkaline phosphatase were 
conducted. Results: Triglyceride level was significantly (p=0.001) lowered in the RPT group 
than the corresponding control group. Total cholesterols, LDL, VLDL and HDL levels were 
raised significantly (p=0.05) in the RPT group. The amount of Albumin, Creatinine and Urea 
in serum were significantly (p=0.05) increased in RPT group. Lowering of Triglyceride is 
particularly beneficial in the condition where triglyceride is a burden. Further studies are 
needed to be conducted to reach a concrete decision about its application in human.  
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Introduction 
A large numbers of modern 
medicinal agents have been sourcing from 
the nature in the past (1). Natural plants 
and their constituents are providing the 
primary ideas regarding the searching of 
novel molecule for the treatment of 
diseases. Traditional and natural medicine 
including ayurvedic medicine are still 
remains a popular practice in the 
subcontinent including India, Sri Lanka 
and Bangladesh (2, 3). Ayurvedic 
medicines have a wide access to the large 
number of population in these countries. 
The acceptance of these medicines 
increased due to its integrative approach 
for the prevention and treatment of disease 
through natural remedies. Traditional 
people are getting the benefits of this 
practice from ancient time. But, the uses 
and the safety profile of all of the 
ayurvedic medicines are not ensured 
scientifically (4, 5). Moreover, the conflict 
between traditional medicines and 
allopathic medicine are needed to be 
addressed scientifically in the in vivo and 
in vitro experimental model.  
 Raktapittantaka Louha (RPT) is a 
preparation of fruits of Emblica officinalis 
Gaertn. (traditionally known as amalaki), 
fruits of Piper longum iron and sugar. 
Equal mixtures of Emblica officinalis, 
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Piper longum and sugar are mixed with the 
ashes of iron. RPT preparation uses to get 
relieve from blood bile and sour bile (6).  
RPT is included (page 303) in the 
Bangladesh National Formulary of 
Ayurvedic Medicine 1992 which is 
Approved by the Government of 
Bangladesh, Ministry of Health and 
Family Welfare, Memo No. Health-
1/Unani-2/89/(Part-1) 116 dated 3-6-1991 
(7). Bangladesh National Formulary of 
Ayurvedic Medicine is compiled by the 
National Unani and Ayurvedic Formulary 
Committee and published by the 
Bangladesh Board of Unani and Ayurvedic 
Systems of Medicine, 38, Bangabandhu 
Avenue, Dhaka-1000 under the authority 
vested in the Board vide section 13(j) of 
the Bangladesh Unani and Ayurvedic 
practitioners Ordinance, 1983 in 
collaboration with the World Health 
Organization.  
Raktapittantaka Louha is used for 
many therapeutic purpose including 
hyperacidity, non ulcer dyspepsia 
[amlapitta], hemorrhagic diseases 
[raktapitta] and anaemia (8). Composition 
of RPT is shown in Table 1. The principle 
component of RPT is Emblica officinalis 
[amalaki]. Aqueous extract of Emblica 
officinalis has an effect on immunity (9), 
provides hypotensive (10), analgesic (11) 
and anti-inflammatory (11) actions. E. 
officinalis possesses antioxidant activity 
(12), gastro-protective activity (13), cyto-
protective, immunomodulating action (14), 
radiation protective activity (12) and 
reduces iron overload-induced liver 
damage (15). 
 
Table1: Plants and ingredients used in the formulation of Raktapittantaka Louha (RPT) (16, 
17). 
Name of Plants Used parts Botanical Name Family Amount 
Amalaki Fruit powder Emblica officinalis Euphorbiaceae 1 part 
Krsna (pippali) Fruit Piper longum Piperaceae 1 part 
Lauha (bhasma)  Iron 1 part 
Sita    1 part 
 
The plant components of RPT have 
large range of activities. Some of those 
activities are beneficial and few of them 
are not in favor of human. Hence, 
biochemical effect of the RPT preparation 
is needed to determine. Liver functions 
might be influenced by RPT components. 
Reduction of SGOT, SGPT, glutathione-S-
transferase levels and DNA synthesis (18), 
and selective cytotoxicity against tumor 
and non-tumor cell lines (19) were shown 
by Emblica officinalis. Another plant 
component of RPT is Piper longum which 
is traditionally used for the treatment of 
intestinal ailments. Iron has been used for 
treating many diseases including anemia 
(20, 21). 
 
Aim of the study 
Considering the widespread use of 
Ayurveda as the popular form of 
traditional medicine in Bangladesh, one 
cannot emphasize enough the need for 
establishing the safety profiles of 
Ayurvedic drugs. Keeping in mind, the 
present research work on Ayurvedic 
formulation, Raktapittantaka Louha (RPT) 
explores a spectrum of its toxicological 
aspects utilizing experimental animals. We 
aim to explore the possible toxicological 
profile of the components of RPT as a 
whole and in some extent justify the 
pharmacological uses. The research was 
carried out in order to characterize the 
chronic toxicological profile of the 
marketed Ayurvedic medicinal preparation 
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RPT on the following aspects: a) Serum 
protein/albumin b) Lipid profile c) Liver 
function test d) Kidney function test e) 
Serum Uric acid and f) Serum enzymatic 
activity 
 
Hypothesis 
Previous research studies have 
been reported many activities of 
Raktapittantaka Louha (RPT). In our 
present study we thought that RPT may 
have a wide range of potential activities. 
RPT may improve the cholesterol profile; 
including the lowering of LDL, VLDL, 
Triglycerides. It may helps to enhance the 
HDL levels in the blood. It is also thought 
that RPT can improve the Liver enzymes 
and may affect the serum protein/albumin, 
serum enzymes levels in the body. 
 
Materials and Methods 
The Liquid Ayurvedic formulation 
Raktapittantaka Louha (RPT) was 
collected from Sri Kundeswari 
Aushadhalaya Ltd., Chittagong, 
Bangladesh. The liquid drug RPT was 
administered per oral route at a dose of 20 
ml/kg body weight to maintain optimal 
dosage accuracy without contributing 
much to the total increase in the body 
fluid. However, ketamine were 
administered intra-peritoneally (500 
mg/kg). Forty eight-week old albino male 
rats (Rattus novergicus : Sprague-Dawley 
strain), bred and maintained at the Animal 
House of the Department of Pharmacy, 
Jahangirnagar University, Savar, Dhaka, 
Bangladesh were used in the toxicological 
experiment. These animals were 
apparently healthy and weighed 50-70 g. 
The animals were housed in a well 
ventilated hygienic experimental animal 
house under constant environmental and 
adequate nutritional conditions throughout 
the period of the experiment. All of the 
rats were kept in plastic cages having 
dimensions of 30 x 20 x 13 cm and soft 
wood shavings were employed as bedding 
in the cages. Feeding of animals was done 
ad libitum, along with drinking water and 
maintained at natural day night cycle. 
They were fed with “mouse chow” 
(prepared according to the formula 
developed at BCSIR, Dhaka). All 
experiments on rats were carried out in 
absolute compliance with the ethical guide 
for care and use of laboratory animals. 
Before starting an experiment the animals 
were carefully marked on different parts of 
their body, which was later used as 
identification mark for a particular animal, 
so that the response of a particular rat prior 
to and after the administration could be 
noted separately. A group of equal number 
of rat as the drug treated group was 
simultaneously employed in the 
experiment. They were administered with 
distilled water as placebo as par the same 
volume as the drug treated group for the 
same number of days and this group 
served as the control. Prior to the 
experiment, they were randomly divided 
into 2 groups of 10 animals. Thus ten rats 
were taken for each group for both control 
and the experimental group. 
 
Biochemical Experiment 
After acclimatization, 
administration of the ayurvedic medicinal 
preparation was done by intra-gastric 
syringe. Administration of the extract was 
between the hours of 10 am and noon. At 
the due of the 46-days treatment period, 
the animals were fasted for 18 hours and 
also twenty-four hours after the last 
administration, the animals were 
anaesthetized using ketamine (500 mg/kg). 
Blood samples were collected from post 
vena cava and transferred into heparinised 
tubes immediately. Preparation of Plasma: 
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Blood was then centrifuged at 4,000 g for 
10 min using bench top centrifuge (MSE 
Minor, England) to remove red blood cells 
and recover plasma. Plasma samples were 
separated and were collected using dry 
Pasteur pipette and stored in the 
refrigerator for analyses. All analyses were 
completed within 24 h of sample 
collection. Determination of Biochemical 
Parameters: Biochemical analysis was 
carried out on serum, to assess the state of 
the liver and kidney. Biochemical studies 
involved analysis of parameters such as 
lipid profile, total protein, serum albumin, 
blood urea nitrogen, bilirubin (total and 
direct), creatinine, and liver enzymes such 
as aspartate aminotransferase (AST), 
alanine aminotransferase (ALT) and 
alkaline phosphatase (ALP).  
 Total protein content of the samples was 
assayed by the Biuret method (22). Serum 
albumin concentration was determined 
using the method of Dumas (1997) (23). 
Triglycerides and total cholesterol 
concentration as well as protein content 
were evaluated using assay kits (purchased 
from Sigma Chemical Co, St Louis, MO, 
USA). Serum total cholesterol and high-
density lipoprotein cholesterol were 
determined using Randox Laboratory kit 
reagents. Serum triacylglycerol level was 
estimated using Randox Laboratory test 
kit. Low density lipoprotein (LDL) 
cholesterol was determined by differential 
substraction of the sum of the cholesterol 
fractions from the total cholesterol. The 
method of Evelyn and Malloy (1938) was 
employed to determine the serum bilirubin 
concentration of the samples (24). The 
procedure of Tietz et al (1994) was used to 
determine serum creatinine concentration 
while the serum urea concentration was 
determined by the method of Kaplan 
(1965) (25, 26). Alkaline phosphatase 
activities were determined using the 
method as described by King and King 
(1954) (27). The absorbance’s of all the 
tests were determined using 
spectrophotometer (UV-Visible 
Spectrophotometer Model No. UV-1601 
PC). 
 
Data Analysis 
The group data are expressed as 
Mean ± SEM (Standard Error of the 
Mean). Unpaired "t" tests were conducted 
for statistical significance tests. SPSS 
(Statistical Package for Social Science) for 
WINDOWS (Version 11) was applied for 
data analysis. Differences between groups 
were considered significant at p =0.05, 
0.01 and 0.001. 
 
Study, observations and results 
There were no changes (P>0.05) in 
the total protein and albumin content in the 
plasma between control and 
Raktapittantaka Louha (RPT) group (see 
table 2). None of the results were 
significantly different from their 
corresponding control values. Albumin 
content in the plasma was increased 
significantly (p=0.05) between control and 
Raktapittantaka Louha (RPT) group. 
Triglycerides content in the plasma was 
significantly (P=0.05) decreased in the 
RPT rats. On the contrary total cholesterol, 
LDL, VLDL and HDL content in the 
plasma were surprisingly increased 
(P=0.05). Bilirubin content in the plasma 
was remaining unchanged. Creatinine and 
Urea content in the plasma were 
significantly (P=0.05) increased in the 
RPT group of rats from their 
corresponding control values. Enzyme 
activity analysis showed that sGPT, sGOT 
and ALP levels were remain unchanged in 
both RPT and control group of rats. 
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Table 2: Biochemical parameters of control and Raktapittantaka Louha (RPT) rats. Albumin 
level was increased. Triglycerides (TG), Very high density lipoprotein (VLDL), Low density 
lipoprotein (LDL) and High density lipoprotein (HDL) levels were increased. Serum 
Creatinine and urea levels were increased. Serum glutamic pyruvate transaminase (sGPT), 
serum glutamic oxaloacetic transaminase (sGOT), alkaline phosphatase (ALP) were remain 
unchanged. 
 
 Male Female 
 Control 
(n=10) 
RPT 
(n=10) 
P Value Control 
(n=10) 
RPT 
(n=10) 
P Value 
Total protein 5629.09  ±  
65.89 
5976.22 ± 
93.94 
0.048* 5384.66 ± 
60.43 
5828.99 ± 
73.42 
0.058 
Albumin 4517.12 ± 
117.60 
5119.13 ± 
83.67 
0.001*** 4221.30 ± 
75.56 
4724.83 ± 
92.28 
0.003** 
Triglycerides 96.47 ±  
1.11 
86.72  ±  
1.95 
0.001*** 97.96  ±  
3.59 
80.52  ±  
2.22 
0.001*** 
Total 
Cholesterol 
68.18 ±  
1.69 
78.98  ±  
1.58 
0.001*** 75.24  ±  
1.64 
85.80  ±  
1.63 
0.008** 
VLDL 14.75  ± 
0.76 
18.89  ±  
0.58 
0.001*** 17.74  ±  
0.43 
20.48  ±  
0.59 
0.001*** 
LDL 19.1  ±  
0.77 
23.97  ± 
0.82 
0.001*** 19.65  ±  
0.69 
23.02  ±  
0.77 
0.038* 
HDL 33.01  ±  
0.88 
39.85  ±  
1.09 
0.001*** 34.37  ±  
1.01 
39.59  ±  
0.99 
0.041* 
Bilirubin 0.12  ±  
0.002 
0.13  ±  
0.002 
0.729 0.07  ±  
0.004 
0.11  ±  
0.004 
0.792 
Creatinine 0.94  ±  
0.012 
1.03  ±  
0.02 
0.041* 0.97  ±  
0.04 
1.16  ±  
0.039 
0.036* 
Urea 65.86  ±  
1.04 
70.30  ±  
0.89 
0.048* 57.53  ±  
1.24 
64.20  ±  
1.05 
0.013* 
Uric acid 2.57  ±  
0.05 
2.97  ±  
0.09 
0.009* 2.79  ±  
0.09 
3.22  ±  
0.08 
0.012* 
sGPT 60.27  ±  
0.12 
60.81  ±  
0.17 
0.836 50.16  ±  
0.14 
50.69  ±  
0.14 
0.904 
sGOT 101.73  ±  
0.30 
102.83  ±  
0.30 
0.801 82.50  ±  
0.20 
833.35  ±  
0.27 
0.866 
ALP 43.56  ±  
0.10 
43.06  ±  
0.17 
0.797 35.45  ±  
0.10 
34.91  ±  
0.019 
0.802 
                                               Note: *p<0.05, **p<0.01, ***p<0.001  
 
 
Discussion 
In the present study toxicological 
and pharmacological profile of 
Raktapittantaka Louha (RPT) was 
investigated in the animal model. 
Experimental results demonstrated no 
changes of total protein content in the 
blood plasma. This result indicates no 
effect of RPT preparation on the protein 
level in animal. An increased level of 
albumin was found in the RPT animal 
group which indicates that the component 
of RPT can affect the albumin level. The 
component of RPT Emblica officinalis has 
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albumin improving properties. Previous 
findings (28) also support our present 
result.  
Result of the present study demonstrated 
that only the triglyceride level was reduced 
after administration of RPT.  RPT 
component/(s) might affect the reduction 
of triglyceride in the plasma. RPT 
components might have this property due 
to the presence of saponins and 
phytosterols. It is noted that Emblica 
officinalis was proven to have triglyceride 
lowering activity in previous research 
paper done by Nain et al., in 2012 (29, 30). 
Moreover, Piper longum was proved to 
have antihyperlipidemic compounds by Jin 
et al., in 2009 (31). Other lipid 
components of the blood such as LDL, 
VLDL even HDL were enhanced after 
RPT administration.  
Our result shows the increased level of 
Creatinine and Urea after the 
administration of RPT preparation. 
Completely opposite finding (decreased 
level of creatinine and urea) was reported 
by Nain et al., in 2012 after the 
administration of Emblica officinalis in the 
streptozotocin-induced type-2 diabetes 
mellitus (T2DM) rats (29) and no change 
was observed by Chen et al., in 2009 (32). 
 
Conclusions 
In this study toxicological and 
pharmacological aspects of 
Raktapittantaka Louha (RPT) was 
investigated. Raktapittantaka Louha 
possesses a wide range of pharmacological 
activities. Triglyceride lowering action 
was found which is particularly beneficial. 
Ayurvedic preparation generally consists 
of multiple plants and varieties of 
chemical constituents in their different 
parts as well. Further studies should be 
conducted to explore the chemical 
constituent/(s) responsible to exhibit the 
pharmacological and toxicological profiles 
of RPT preparation. We only suggest that 
RPT preparation may be prescribed under 
careful monitoring by the registered 
physicians. 
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